A detailed history of Meeder Asset Management Inc transactions in Organon & Co. stock. As of the latest transaction made, Meeder Asset Management Inc holds 8,843 shares of OGN stock, worth $135,121. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,843
Previous 8,843 -0.0%
Holding current value
$135,121
Previous $183,000 7.65%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$17.45 - $21.96 $27,274 - $34,323
1,563 Added 21.47%
8,843 $183,000
Q1 2024

May 07, 2024

SELL
$13.78 - $18.8 $47,541 - $64,860
-3,450 Reduced 32.15%
7,280 $136,000
Q4 2023

Jan 25, 2024

SELL
$10.95 - $17.32 $4,303 - $6,806
-393 Reduced 3.53%
10,730 $154,000
Q3 2023

Nov 13, 2023

BUY
$16.59 - $23.77 $7,548 - $10,815
455 Added 4.27%
11,123 $193,000
Q2 2023

Aug 11, 2023

BUY
$19.27 - $24.63 $59,216 - $75,687
3,073 Added 40.46%
10,668 $222,000
Q1 2023

May 15, 2023

SELL
$21.42 - $32.08 $21,805 - $32,657
-1,018 Reduced 11.82%
7,595 $178,000
Q4 2022

Feb 14, 2023

SELL
$23.31 - $28.61 $24,965 - $30,641
-1,071 Reduced 11.06%
8,613 $240,000
Q3 2022

Nov 14, 2022

BUY
$23.4 - $34.25 $16,918 - $24,762
723 Added 8.07%
9,684 $226,000
Q2 2022

Aug 08, 2022

BUY
$31.66 - $38.9 $1,931 - $2,372
61 Added 0.69%
8,961 $303,000
Q1 2022

May 10, 2022

BUY
$30.45 - $39.36 $193,814 - $250,526
6,365 Added 251.08%
8,900 $310,000
Q4 2021

Feb 11, 2022

SELL
$28.67 - $37.13 $417,635 - $540,872
-14,567 Reduced 85.18%
2,535 $77,000
Q3 2021

Nov 08, 2021

BUY
$28.63 - $35.64 $437,580 - $544,721
15,284 Added 840.7%
17,102 $561,000
Q2 2021

Aug 09, 2021

BUY
$28.45 - $38.0 $51,722 - $69,084
1,818 New
1,818 $55,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.